Pliant Therapeutics, Inc. (PLRX)

Pliant Therapeutics Statistics

Total Valuation

PLRX has a market cap or net worth of $72.44 million. The enterprise value is -$89.40 million.

Market Cap	72.44M
Enterprise Value	-89.40M

Important Dates

The last earnings date was Wednesday, March 11, 2026, after market close.

Earnings Date	Mar 11, 2026
Ex-Dividend Date	n/a

Share Statistics

PLRX has 61.91 million shares outstanding. The number of shares has increased by 1.37% in one year.

Current Share Class	61.91M
Shares Outstanding	61.91M
Shares Change (YoY)	+1.37%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	2.73%
Owned by Institutions (%)	76.98%
Float	60.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.40
P/TBV Ratio	0.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.00, with a Debt / Equity ratio of 0.16.

Current Ratio	12.00
Quick Ratio	11.72
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-58.65

Financial Efficiency

Return on equity (ROE) is -61.55% and return on invested capital (ROIC) is -32.65%.

Return on Equity (ROE)	-61.55%
Return on Assets (ROA)	-30.15%
Return on Invested Capital (ROIC)	-32.65%
Return on Capital Employed (ROCE)	-71.85%
Weighted Average Cost of Capital (WACC)	10.05%
Revenue Per Employee	n/a
Profits Per Employee	-$3.05M
Employee Count	49
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.41% in the last 52 weeks. The beta is 1.28, so PLRX's price volatility has been higher than the market average.

Beta (5Y)	1.28
52-Week Price Change	-20.41%
50-Day Moving Average	1.26
200-Day Moving Average	1.43
Relative Strength Index (RSI)	39.00
Average Volume (20 Days)	512,022

Short Selling Information

The latest short interest is 3.80 million, so 6.14% of the outstanding shares have been sold short.

Short Interest	3.80M
Short Previous Month	3.79M
Short % of Shares Out	6.14%
Short % of Float	6.31%
Short Ratio (days to cover)	5.96

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-150.07M
Pretax Income	-149.34M
Net Income	-149.34M
EBITDA	-148.38M
EBIT	-150.07M
Earnings Per Share (EPS)	-$2.43

Balance Sheet

The company has $190.94 million in cash and $29.11 million in debt, with a net cash position of $161.84 million or $2.61 per share.

Cash & Cash Equivalents	190.94M
Total Debt	29.11M
Net Cash	161.84M
Net Cash Per Share	$2.61
Equity (Book Value)	181.21M
Book Value Per Share	2.95
Working Capital	180.08M

Cash Flow

In the last 12 months, operating cash flow was -$128.34 million and capital expenditures -$374,000, giving a free cash flow of -$128.71 million.

Operating Cash Flow	-128.34M
Capital Expenditures	-374,000
Depreciation & Amortization	1.70M
Net Borrowing	-32.27M
Free Cash Flow	-128.71M
FCF Per Share	-$2.08

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PLRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.37%
Shareholder Yield	-1.37%
Earnings Yield	-206.16%
FCF Yield	-177.68%

Analyst Forecast

The average price target for PLRX is $2.67, which is 128.21% higher than the current price. The consensus rating is "Hold".

Price Target	$2.67
Price Target Difference	128.21%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-4.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2